National Health Investors, Inc. reported $432M of revenue over the trailing twelve months, +24% on the year before. 10 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $432M (to Q2 2026). Net income: $167M, trailing twelve months to Q2 2026. Free cash flow: −$168M, trailing twelve months to Q2 2026. Operating margin: 33%, trailing twelve months to Q2 2026.

NHINational Health Investors, Inc.

Real Estate

$64.85-14% 1Y

$64.85

$63.9852 weeks$90.00

NHI as reported

National Health Investors, Inc. reported $432M of revenue over the trailing twelve months, +24% on the year before. 10 reported series are charted on this page, each one as filed.

$432M

Revenue, trailing twelve months · to Q2 2026 · +24% against the twelve months before

Net income: $167M
Net income · +17% year on year · trailing twelve months to Q2 2026
Free cash flow: −$168M
Free cash flow · +106% year on year · trailing twelve months to Q2 2026
Operating margin: 33%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for NHI, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$432M	+24%	Q2 2026
Net income	$167M	+17%	Q2 2026
EPS	$3.46	+10%	Q2 2026
Operating margin	33%	n/a	Q2 2026
Net margin	38%	n/a	Q2 2026
ROE	9.9%	n/a	Q2 2026
ROA	5.3%	n/a	Q2 2026
ROIC	4.0%	n/a	Q2 2026
Free cash flow	−$168M	+106%	Q2 2026
P/E	18.7	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.